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Abstract
Background: Street-involved youth contend with an array of health and social challenges,
including elevated rates of blood-borne infections and mortality. In addition, there has been
growing concern regarding high-risk drug use among street-involved youth, in particular injection
drug use. We undertook this study to examine the prevalence of injection drug use and associated
risks among street-involved youth in Vancouver, Canada.
Methods: From September 2005 to November 2007, baseline data were collected for the At-Risk
Youth Study (ARYS), a prospective cohort of street-recruited youth aged 14 to 26 in Vancouver,
Canada. Using multiple logistic regression, we compared youth with and without a history of
injection.
Results: The sample included 560 youth among whom the median age was 21.9 years, 179 (32%)
were female, and 230 (41.1%) reported prior injection drug use. Factors associated with injection
drug use in multivariate analyses included age ≥ 22 years (adjusted odds ratio [AOR] = 1.18, 95%
CI: 1.10–1.28); sex work involvement (AOR = 2.17, 95% CI: 1.35–3.50); non-fatal overdose (AOR
= 2.10, 95% CI: 1.38–3.20); and hepatitis C (HCV) infection (AOR = 22.61, 95% CI: 7.78–65.70).
Conclusion: These findings highlight an alarmingly high prevalence of injection drug use among
street-involved youth and demonstrate its association with an array of risks and harms, including
sex work involvement, overdose, and HCV infection. These findings point to the need for a broad
set of policies and interventions to prevent the initiation of injection drug use and address the risks
faced by street-involved youth who are actively injecting.
Background
Street-involved youth are increasingly common in North
American cities and are a population at heightened risk
for an array of health and social problems [1]. In Canada
and the United States, it is estimated that between 4% and
7% of youth between the ages of 14 and 26 are absolutely,
periodically, or temporarily without safe and stable shel-
ter [2,3]. Since the definition of "street youth" is often
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heavily involved in the street economy [4], the proportion
of youth who fall into this category may be significantly
greater.
Compared to the general population, street-involved
youth contend with a variety of health-related risks and
challenges [1], including elevated rates of mental illness
[5], blood-borne infections [5-7], sexually transmitted
infections [8], and violence [9,10]. Recent evidence from
Montreal, Canada suggests that street-involved youth, in
comparison to the general population, face an 8 to 11
times higher risk of mortality [11].
There have also been persistent concerns regarding high-
risk substance use among street-involved youth in settings
throughout the world [12-14]. In particular, in light of the
associated risks for human immunodeficiency virus (HIV)
and hepatitis C infection (HCV), increasing attention has
been paid to the initiation of injection drug use within
this population. This has led to calls for an updating of the
risk hierarchy so that the prevention of injection drug use
is given greater attention [15]. However, the prevalence of
injecting and associated harms among street-involved
youth has not been studied in many urban areas in North
America [13,16,17], and, outside of Montreal [18], little is
known about the epidemiology of injection drug use
among street-involved youth in Canada. Past estimates
suggest there are at any time upwards of 150,000 young
people in Canada who are absolutely, periodically or tem-
porarily without shelter [2]. However, there remain many
challenges associated with estimating the size of this pop-
ulation given the transitory nature of street youth and lack
of reliable counts of street youth (e.g., Census data, etc).
Vancouver, Canada has been the site of co-occurring epi-
demics of injection drug use, HIV, overdose, and HCV.
However, while much study has been devoted to adult
injection drug users (IDU) in this setting, little is known
about the prevalence and associated risks of injection drug
use among the city's growing street youth population
[19]. Although reliable estimates are lacking, it has been
suggested that there are between 500 to 1000 street youth
living on Vancouver streets each day [20]. While an
increasing number of studies have described the predic-
tors of the initiation and cessation of injection drug use
[18,21-23], there have been few studies that have com-
pared the characteristics of drug-using street youth who
have and have not injected. Therefore, we undertook this
study to assess the prevalence and related risks and harms
of injection drug use among a cohort of drug-using street-
involved youth in Vancouver.
Methods
The At-Risk Youth Study (ARYS) is a prospective cohort
study of Vancouver street-involved youth that has been
described in detail previously [19]. Briefly, participants
were recruited through snowball sampling and extensive
street-based outreach. Persons were eligible for the study
if they were between 14 and 26 years of age, had used
illicit drugs other than or in addition to marijuana in the
past 30 days, and provided informed consent. At baseline
and at semi-annual follow-up visits, participants com-
plete an interviewer-administered questionnaire and pro-
vide blood samples for HIV and hepatitis C (HCV)
serology. The questionnaire elicits demographic data and
information regarding injection and non-injection illicit
drug use, HIV risk behaviors, income generation, encoun-
ters with police, health service utilization, and sexual
activity. The questionnaire is based on a previous instru-
ment developed for adult drug users, and has been found
to reliably identify factors associated with HIV infection,
mortality, and other harms [24-26]. All participants
received a monetary stipend of $20 after each visit. The
study has been approved by the University of British
Columbia/Providence Health Care Research Ethics Board.
The present study was conducted to evaluate the preva-
lence of injection drug use and related risks and harms
among street-involved youth who completed baseline
study visits between September 2005 and November
2007. Although ARYS is a prospective cohort study, given
the low incidence of initiation into injection drug use, a
longitudinal study of injection drug use initiation among
ARYS participants was not possible at this time. The pri-
mary outcome of interest was reporting any history of
injection drug use (i.e., lifetime prevalence of injection
drug use). Other self-reported variables of interest were
selected based on a review of the documented harms asso-
ciated with injection drug use, and included: age; gender;
Aboriginal ethnicity; history of incarceration; history of
sex work involvement (defined as exchanging sex for
money, drugs, shelter, or gifts); history of drug dealing;
currently having a warrant for one's arrest; and history of
non-fatal overdose. Variable definitions were consistent
with prior studies involving the ARYS cohort [27,28].
Serologic outcomes considered included HIV- and HCV-
positive status.
As a first step, we conducted a univariate analyses in
which those who did and did not report a history of injec-
tion drug use were compared using Pearson's Chi-square
test and the Wilcoxon rank test. Fisher's exact test was used
when one or more of the cells contained values less than
or equal to five. As a second step, a multivariate model
was then prepared using an a priori defined statistical
approach whereby variables that were p < 0.05 in univari-
ate analyses were included in a fixed logistic regression
model. Variables that remained significant at p < 0.05
were regarded as factors significantly associated with the
outcome of interest. All statistical analyses were per-Page 2 of 7
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and all p-values are two sided.
Results
In total, 560 participants were recruited and included in
the present analyses. Of these participants, 179 (32%)
were female and 131 (23.4%) were of Aboriginal ancestry.
The median age was 21.9 years (interquartile range =
19.8–23.9). In total, 230 (41.1%) participants reported
injection drug use. Factors associated with injection drug
use in univariate analyses are presented in Table 1 and
include: age ≥ 22 year (odds ratio [OR] = 2.67, 95% con-
fidence interval [CI]: 1.89–3.79, p < 0.001); history of
incarceration (OR = 2.04, 95% CI: 1.31–3.18, p < 0.001);
sex work involvement (OR = 2.86, 95% CI: 1.89–4.32, p <
0.001); drug dealing (OR = 1.61, 95% CI: 1.10–2.42, p =
0.023); having a warrant for one's arrest (OR = 1.56, 95%
CI: 1.03–2.33, p = 0.037); non-fatal overdose (OR = 2.76,
95% CI: 1.92–3.97, p < 0.001); and HCV infection (OR =
29.51, 95% CI: 10.55–82.53, p < 0.001).
As shown in Table 2, factors found to be independently
associated with injection drug use in multivariate logistic
regression analyses included: age = 22 years (adjusted
odds ratio [AOR] = 1.18, 95% CI: 1.10–1.28, p < 0.001);
sex work involvement (AOR = 2.17, 95% CI: 1.35–3.50, p
= 0.001); non-fatal overdose (AOR = 2.10, 95% CI: 1.38–
3.20, p < 0.001); and HCV infection (AOR = 22.61, 95%
CI: 7.78–65.70, p < 0.001).
Discussion
In the present analysis, we found that injection drug use
was common among street-involved youth in Vancouver,
with approximately 40% of the cohort reporting a history
of injection drug use. In a multivariate analysis, reporting
a history of injection drug use was associated with older
age, sex work involvement, non-fatal overdose, and hepa-
titis C infection.
The high prevalence of injection drug use among street-
involved youth in Vancouver is slightly lower than
observed in Montreal, Canada (41% versus 60%) [18],
although somewhat higher than observed in some US cit-
ies [17]. Injection drug use among street-involved youth
in this study was associated with several markers of risk,
including sex work involvement. This is consistent with
previous studies from various settings demonstrating a
relationship between injection drug use and sex work
among street-involved youth [29-32], studies which have
also suggested that the co-occurrence of injection drug use
and sex work places street-involved youth at elevated risk
for HIV infection and other sexually transmitted infec-
tions. The association between sex work and injection
drug use observed in the present study is also consistent
with previous research demonstrating that injection drug
users (IDU) frequently resort to high-risk income generat-
ing activities, such as sex work [33], to support their drug
use and basic survival needs [34], and that sex work is
often linked to drug scene exposure [35]. However, previ-
ous studies from our setting have also suggested a strong
relationship between the initiation of sex work among
street-involved youth and childhood emotional and sex-
ual abuse [36]. While the forces that prompt the co-occur-
rence of sex-work involvement and injection drug use will
require further elucidation, the finding of an association
between sex work and injection drug use among street-
involved youth in this settings is of immediate concern,
given evidence suggesting that sex work involvement is a
strong predictor of premature mortality among young
IDU in Vancouver [25].
Injection drug use was also associated with non-fatal over-
dose in this study. This is consistent with other studies
indicating a high rate of prior non-fatal overdose among
IDU [37,38] and a relationship between elevated risk for
overdose and injecting as a route of drug administration
[39]. Although non-fatal overdose among IDU is typically
associated with heroin use [39], it is notable that crystal
methamphetamine use is highly prevalent among street-
involved youth in Vancouver and has been associated
with non-fatal overdose among this population and adult
IDU [27,40].
The finding that injection drug use was strongly associated
with an elevated risk for HCV infection among youth in
this study is consistent with a previous study of street-
involved youth in Montreal and is not surprising, given
the high prevalence of HCV infection among adult IDU in
Vancouver [41] and the fact that injection drug use is an
efficient mode of HCV transmission. Indeed, previous
studies undertaken within North America suggest that
many young IDU acquire HCV soon after initiating inject-
ing, with the estimated time to HCV infection among this
population being 1 to 2 years [42,43].
These findings reinforce previous calls for an updating of
the risk prevention hierarchy so that the transition to
injection drug use receives greater attention [15]. Indeed,
studies have shown that the risk for acquisition of blood-
borne infections is high after the onset of injecting [44],
and therefore interventions that prevent the initiation of
injecting among street-involved youth are needed, includ-
ing those that target individuals (e.g., addiction treat-
ment), as well as those that address the broader social,
structural, and environmental determinants of injection
drug use [45]. Unfortunately, few evidence-based
approaches of this kind have been described. Given that
older age (> 22 years) was associated with injection drug
use in this study, future efforts should include delivering
prevention interventions to high-risk street youth not yetPage 3 of 7
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Characteristic Yes n = 230 (41.1%) No n = 330 (58.9%) Odds Ratio (95% CI) p - value
Median age
≥ 22 years 82 (35.6) 197 (59.7) 2.67 (1.89–3.79) <0.001
< 22 years 148 (64.4) 133 (40.3)
Gender
Female 67 (29.1) 112 (33.9) 0.80 (0.56–1.15) 0.233
Male 163 (70.9) 218 (66.1)
Aboriginal ethnicity
Yes 51 (22.2) 80 (24.2) 0.89 (0.60–1.33) 0.570
No 179 (77.8) 250 (75.8)
Incarceration
Yes 197 (85.7) 246 (74.5) 2.04 (1.31–3.18) <0.001
No 33 (14.3) 84 (25.5)
Sex work
Yes 74 (32.2) 47 (14.2) 2.86 (1.89–4.32) <0.001
No 156 (67.8) 283 (85.8)
Drug dealing
Yes 187 (81.3) 241 (73.0) 1.61 (1.10–2.42) 0.023
No 43 (18.7) 89 (27.0)
Warrants*
Yes 60 (26.0) 61 (18.5) 1.56 (1.03–2.33) 0.037
No 170 (74.0) 269 (81.5)
Overdose
Yes 107 (46.5) 79 (23.9) 2.76 (1.92–3.97) <0.001
No 123 (53.5) 251 (76.1)
HCV-positive†
Yes 62 (26.9) 4 (1.2) 29.51(10.55–82.53) <0.001
No 167 (72.6) 318 (96.4)
?Page 4 of 7
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cate that street-involved youth are at heightened risk for
an array of harms through both drug use (e.g., overdose
and HCV infection) and related activities (e.g., sex work
involvement), interventions that reduce harm among
street-involved youth who have taken up injecting are also
needed. These include conventional harm reduction inter-
ventions [46], such as youth-friendly needle exchange
programs, but also social and structural interventions that
aim to mediate the risk environment of youth who inject
drugs and exchange sex, including mobile service delivery
and socio-legal reforms that facilitate safe sex work set-
tings [47,48].
Our study has several limitations. First, like most other
cohort studies involving high-risk youth, ARYS is not a
random sample, and therefore our study findings may not
be generalize well to the larger population of street youth
in Vancouver. Further, given the differences across set-
tings, including differences in the types of drugs used in
different urban environments, our findings may not gen-
eralize well to street youth in other settings. Second, we
relied on several measures of self-report, and therefore
some response biases may have affected our results. In
particular, we may have underestimated some sensitive
behaviors and experiences, including injection drug use
and sex work involvement. Lastly, this study design is
HIV-positive‡
Yes 7 (3.0) 8 (2.4) 1.64 (0.58–4.61) 0.427
No 221 (96.1) 319 (96.7)
* Warrants refers to having a warrant for arrest
† HCV refer to hepatitis C virus
‡ HIV refers to human immunodeficiency virus
 Values do not add up to 100% due to missing tests results
Table 1: Factors associated with injection drug use among street-involved youth (n = 560). (Continued)
?
?
Table 2: Logistic regression analysis of factors associated with injection drug use among street-involved youth (n = 560).
Variable Adjusted Odds Ratio (AOR) 95% Confidence Interval (95% CI) p - value
Age
(≥ 22 vs. < 22 years) 1.18 (1.10 – 1.28) <0.001
Incarceration
(yes vs. no) 1.54 (0.88 – 2.70) 0.124
Sex work
(yes vs. no) 2.17 (1.35 – 3.50) 0.001
Overdose
(yes vs. no) 2.10 (1.38 – 3.20) <0.001
Drug dealing
(yes vs. no) 1.20 (0.73 – 1.97) 0.472
Warrants*
(yes vs. no) 1.18 (0.73 – 1.93) 0.498
HCV-positive
(yes vs. no) 22.61 (7.78 – 65.70) <0.001
* Warrants refers to having a warrant for arrestPage 5 of 7
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ships cannot be inferred.
Conclusion
In summary, we found a high prevalence of injection drug
use among street-involved youth in Vancouver. Impor-
tantly, injection drug use was associated with several
markers of elevated risk and harm, including sex work
involvement and overdose, as well as hepatitis C infec-
tion. These findings point to the need for continued
efforts to reduce the initiation into injection use, as well as
efforts to minimize the risks and harms experienced by
street-involved youth who already inject.
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